Voiding Disorders in Long-Term Care
- Wed, 12/10/08 - 4:31pm
- 0 Comments
- 3278 reads
Michael Srulevich, DO, MPH, and Anita Chopra, MD, FACP, CMD
Author Affiliations: Dr. Srulevich is a faculty member, Department of Medicine, in the Division of Geriatric Medicine, Crozer-Chester Medical Center, Upland, PA, and Clinical Assistant Professor of Medicine, Temple University School of Medicine, Philadelphia, PA; and Dr. Chopra is Professor of Medicine, Director of Education and Clinical Programs, New Jersey Institute for Successful Aging, University of Medicine and Dentistry of New Jersey, School of Osteopathic Medicine, Stratford, NJ.
Introduction
As many as half of all residents in long-term care (LTC) facilities suffer from some type of voiding disorder. A broad array of voiding symptoms such as incontinence, burning, frequency, sense of incomplete bladder emptying, and difficulty in initiating voiding affect the lower urinary tract. The primary focus of this article will be to review the pathophysiology and symptoms of common voiding dysfunctions in the LTC setting, understand how they relate to the underlying disease process, and effectively evaluate and manage acute and chronic conditions. Reasons for voiding dysfunction are often multifactorial and can be related to many overlapping comorbid conditions. Management and treatment options are tailored to relief of symptoms, reducing disease burden, and maintaining quality of life.
Pathophysiology of the Aging Lower Urinary Tract and Relation to Symptoms
The aging lower urinary tract undergoes physiologic changes that can result in increased urinary symptoms, such as urgency, frequency, and a sensation of incomplete emptying, which can manifest as urologic disorders. As aging occurs, overall bladder capacity is reduced and post-void residual volumes can become elevated.1 Age-related morphologic changes in the bladder wall, consisting of a decreased ratio of the area density of smooth muscle to connective tissue, occur in both men and women. In addition, detrusor contractility has been shown to decrease in an age-dependent manner.2 An increase in lower urinary tract symptoms (LUTS) is thus age-related but not sex-specific.3,4 In fact, while initially much lower in men, by the seventh decade the prevalence of urge urinary incontinence (UI) is about equal in both genders.
Approximately half of all persons with symptoms of overactive bladder (OAB) suffer from detrusor overactivity.5 In contrast, voiding symptoms, such as the feeling of incomplete emptying or reduced urinary flow, are similar in both sexes until about age 50, when men demonstrate increased rates of voiding symptoms due to benign prostatic hyperplasia (BPH) and obstructive changes.5 In BPH, age-related prostatic enlargement may encroach upon the anatomic structures and cause obstruction of urine flow through the urethra.
Risk Factors for Voiding Dysfunction in the Geriatric Population
In both men and women, the causes of voiding dysfunction are diverse and can involve numerous organ systems. Acute symptoms always warrant further investigation, and reversible causes such as infection, obstruction, and medication side effects must be considered (Table I). If the symptoms are chronic, as is often the case in the LTC setting, the focus of management is to limit the impact of disease burden. Epidemiological evidence in the geriatric population points to cognitive impairment, constipation, parity, medications, genitourinary surgery, obesity, and cardiovascular disease as risk factors for incontinence.6,7 Gammack6 notes that in frail elderly persons, many of these conditions are already present and may be unmodifiable, so prevention should focus on reducing the impact of chronic disease on these related risk factors.
Older adults often take more medications, which can have deleterious effects on bladder control. Drugs with anticholinergic side effects can reduce bladder emptying and may cause urinary retention. The use of diuretics may complicate the management of incontinence.
1. Klausner AP, Vapnek JM. Urinary incontinence in the geriatric population. Mt Sinai J Med 2003;70(1):54-61.
2. Van Mastrigt R. Age dependence of urinary bladder contractility. Neurourol Urodyn 1992;11:315-317.
3. Lepor H, Machi G. Comparison of AUA symptom index in unselected males and females between fifty-five and seventy-nine years of age. Urology 1993;42:36-41.
4. Chai TC, Belville WD, McGuire EJ, Nyquist L. Specificity of the American Urological Association voiding symptom index; Comparison of unselected and selected samples of both sexes. J Urol 1993;150(5 pt 2):1710-1713.
5. Madersbacher H, Madersbacher S. Men’s bladder health: Urinary incontinence in the elderly (Part 1). J Mens Health Gend 2005;2(1);31-37.
6. Gammack JK. Urinary incontinence in the frail elder. Clin Geriatr Med 2004;20(3):453-466, vi.
7. Fonda D, Resnick NM, Kirschner-Hermanns R. Prevention of urinary incontinence in older people. Br J Urol 1998;82(Suppl 1):5-10.
8. Schor JD, Levkoff SE, Lipsitz LA, et al. Risk factors for delirium in hospitalized elderly. JAMA 1992;267:827-831.
9. Palmer MH, German PS, Ouslander JG. Risk factors for urinary incontinence one year after nursing home admission. Res Nurs Health 1991;14:405-412.
10. Jirovec MM. The impact of daily exercise on the mobility, balance and urine control of cognitively impaired nursing home residents. Int J Nurs Stud 1991;28:145-151.
11. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: Report from the Standardisation Sub-Committee of the International Continence Society. Am J Obstet Gynecol 2002:187(1):116-126.
12. Engberg S, Kincade J, Thompson D. Future directions for incontinence research with frail elders. Nurs Res 2004;53(6 Suppl)):S22-S29.
13. Temml C, Haidinger D, Schmidbauer J, et al. Urinary incontinence in both sexes: Prevalence rates and impact on quality of life and sexual life. Neurourol Urodyn 2000;19:259-271.
14. Weiss BD. Selecting medications for the treatment of urinary incontinence. Am Fam Physician 2005;71(2):315-322, 329.
15. Selius BA, Subedi R. Urinary retention in adults: Diagnosis and initial management. Am Fam Physician 2008;77(5):643-650.
16. Rosenstein D, McAnnich JW. Urologic emergencies. Med Clin North Am 2004;88(2):495-518.
17. Deane AM, Worth PH. Female chronic urinary retention. Br J Urol 1985;57(1):24-26.
18. Verhamme KM, Dieleman JP, Van Wijk MA, et al. Nonsteroidal anti-inflammatory drugs and increased risk of acute urinary retention. Arch Intern Med 2005;165(13):1547-1551.
19. Kunin CM, Douthitt S, Dancing J, et al. The association between the use of urinary catheters and morbidity and mortality among elderly patients in nursing homes. Am J Epidemiol 1992;135(1):291-301.
20. Emberton M, Zinner N, Michel MC, et al. Managing the progression of lower urinary tract symptoms/benign prostatic hyperplasia: Therapeutic options for the man at risk. BJU Int 2007;100(2):249-253.
21. McConnell JD, Roehrborn CG, Bautista OM, et al; Medical Therapy of Prostatic Symptoms (MTOPS) Research Group. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostastic hyperplasia. N Engl J Med 2003;349:2387-2398.
22. Djavan B, Chapple C, Milani S, Marberger M. State of the art on the efficacy and tolerability of alpha-1-adrenorecetor antagonsists in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Urology 2004;64:1081-1088.
23. Thomas DR. Pharmacologic management of urinary incontinence. Clin Geriatr Med 2004;20: 511-523, vii-viii.









Post new comment